GLP-1 receptor agonists semaglutide (Ozempic, Wegovy, Rybelsus) and tirzepatide (Mounjaro, Zepbound) are the No
Once-weekly injectable semaglutide 2.4 mg was linked to reductions in body weight and improvements in multiple cardiometabolic parameters for older adults with obesity, according to a pooled analysis of the STEP trials
Bristol Myers Squibb announced direct-to-patient platforms for Eliquis and Sotyktu, under which eligible cash-pay patients can purchase the drug at a 40% discount and greater than 80% discount versus their respective list prices
View Full Study Characterization of 0839 - A tool compound for pre-clinical mode-of-action studies of amylin analogues such as cagrilintide
This streamlined service saves you time and alleviates confusion over insurance requirements
In 2017, 323,700 estimated cases in hospitalized patients, 10,600 estimated deaths (33%), and $1.7 billion estimated attributable healthcare costs [7]